United States:
Mind The Gap: Strengthen Your Patent Portfolio With A White Space Analysis
11 April 2024
Greenberg Traurig, LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Patents buttress and backstop growth for medical technology
(medtech) companies, period. This is especially so for early-stage
ventures staking their claim in the medtech ecosystem. A strategic
patent portfolio is an essential building block to have in place
for a medtech company's growth and success, especially when it
comes to generating revenue or fundraising. And, for a medtech
company at any stage, having a solid patent portfolio can lead to
licensing, joint ventures, and collaboration opportunities with
strategic partners.
Continue reading the full article, published by
MedTech Innovation News Dec. 1, 2023.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
USPTO Embraces AI Tools In New Guidance
Crowell & Moring LLP
On April 11, 2024, the USPTO published its "Guidance on Use of Artificial Intelligence-Based Tools in Practice Before the United States" in the Federal Register (the "Guidance"). As the title suggests...
Breaking Down The EPO's Revised Practice Guidelines
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The guidelines for examination in the European Patent Office instruct on the practice and procedure related to the examination of European patent applications...
USPTO Issues Guidance On Use Of AI-Based Tools
Greenberg Traurig, LLP
On April 11, 2024, the U.S. Patent and Trademark Office (USPTO) issued Guidance on Use of Artificial-Intelligence-Based Tools (Guidance), which applies existing rules and policies...